on April 26, 2004
Published online before print April 26, 2004, doi: 10.1161/01.CIR.0000127956.43874.F2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 27, 2003
From the Departments of Internal Medicine (W.G.L., D.G., X.L., S.G., L.L.S., M.L.M., C.D.S., N.L.W.) and Surgery (L.W.) and the Free Radical and Radiation Biology Program (M.L.M., N.L.W.), University of Iowa, Iowa City; Veterans Affairs Medical Center, Iowa City, Iowa (N.L.W.); and Institute of Cardiovascular Disease Research, First Hospital of Peking University, and Department of Physiology, Health Science Center of Peking University, Beijing, People’s Republic of China (C.T.). * To whom correspondence should be addressed. E-mail: neal-weintraub{at}uiowa.edu.
Background--Ghrelin is a novel growth hormone-releasing peptide that has been shown to improve cachexia in heart failure and cancer and to ameliorate the hemodynamic and metabolic disturbances in septic shock. Because cytokine-induced inflammation is critical in these pathological states and because the growth hormone secretagogue receptor has been identified in blood vessels, we examined whether ghrelin inhibits proinflammatory responses in human endothelial cells in vitro and after administration of endotoxin to rats in vivo. Methods and Results--Human umbilical vein endothelial cells (HUVECs) were treated with or without tumor necrosis factor- Conclusions--Ghrelin inhibits proinflammatory cytokine production, mononuclear cell binding, and nuclear factor-
Revised on November 26, 2003
Accepted on January 28, 2004
Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-
Wei Gen Li MD, PhD, 
B Activation in Human Endothelial Cells
(TNF-), and induction of proinflammatory cytokines and mononuclear cell adhesion were determined. Ghrelin (0.1 to 1000 ng/mL) inhibited both basal and TNF--induced cytokine release and mononuclear cell binding. Intravenous administration of ghrelin also inhibited endotoxin-induced proinflammatory cytokine production in rats in vivo. Ghrelin inhibited H2O2-induced cytokine release in HUVECs, suggesting that the peptide blocks redox-mediated cellular signaling. Moreover, ghrelin inhibited basal and TNF--induced activation of nuclear factor-
B. Des-acyl ghrelin had no effect on TNF--induced cytokine production in HUVECs, suggesting that the antiinflammatory effects of ghrelin require interaction with endothelial growth hormone secretagogue receptors.B activation in human endothelial cells in vitro and endotoxin-induced cytokine production in vivo. These novel antiinflammatory actions of ghrelin suggest that the peptide could play a modulatory role in atherosclerosis, especially in obese patients, in whom ghrelin levels are reduced.
Key words: hormones, peptide • inflammation • endotoxins • monocytes • nuclear factor-
B
This article has been cited by other articles:
 |
|
 |
|
  S. Taddei and A. Virdis Exogenous Ghrelin on Nitric Oxide-Endothelin 1 Imbalance in Metabolic Syndrome: Can We Kill 2 Birds With 1 Stone? Hypertension, November 1, 2009; 54(5): 960 - 961. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, S. Bansal, S. Falk, D. Ljubanovic, and R. Schrier Ghrelin protects mice against endotoxemia-induced acute kidney injury Am J Physiol Renal Physiol, October 1, 2009; 297(4): F1032 - F1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Adelman and L. B. Martin Vertebrate sickness behaviors: Adaptive and integrated neuroendocrine immune responses Integr. Comp. Biol., September 1, 2009; 49(3): 202 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-M. Theil, S. Miyake, M. Mizuno, C. Tomi, J. L. Croxford, H. Hosoda, J. Theil, S. von Horsten, H. Yokote, A. Chiba, et al. Suppression of Experimental Autoimmune Encephalomyelitis by Ghrelin J. Immunol., August 15, 2009; 183(4): 2859 - 2866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yang, Y.-H. Youm, Y. Sun, J.-S. Rim, C. J. Galban, B. Vandanmagsar, and V. D. Dixit Axin expression in thymic stromal cells contributes to an age-related increase in thymic adiposity and is associated with reduced thymopoiesis independently of ghrelin signaling J. Leukoc. Biol., June 1, 2009; 85(6): 928 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Dixit, H. Yang, A. Cooper-Jenkins, B. B. Giri, K. Patel, and D. D. Taub Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation Blood, May 21, 2009; 113(21): 5202 - 5205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Al, L. Ng, P. Tyrrell, J. Bargman, T. Bradley, and E. Silverman Adipokines as novel biomarkers in paediatric systemic lupus erythematosus Rheumatology, May 1, 2009; 48(5): 497 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Balasubramaniam, R. Joshi, C. Su, L. A. Friend, S. Sheriff, R. J. Kagan, and J. H. James Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R893 - R901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, T R Vazquez-Rodriguez, C Gonzalez-Juanatey, J M de Matias, J Martin, P H Dessein, and J Llorca Anti-tumour necrosis factor {alpha} therapy modulates ghrelin in patients with severe rheumatoid arthritis Ann Rheum Dis, November 1, 2008; 67(11): 1644 - 1646. [Full Text] [PDF]
|
|
|
|
|
|
V. D. Dixit Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span J. Leukoc. Biol., October 1, 2008; 84(4): 882 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, B. Sook Jhun, C. Hoon Ha, and Z.-G. Jin Molecular Mechanisms of Ghrelin-Mediated Endothelial Nitric Oxide Synthase Activation Endocrinology, August 1, 2008; 149(8): 4183 - 4192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chorny, P. Anderson, E. Gonzalez-Rey, and M. Delgado Ghrelin Protects against Experimental Sepsis by Inhibiting High-Mobility Group Box 1 Release and by Killing Bacteria J. Immunol., June 15, 2008; 180(12): 8369 - 8377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Vergnano, F. Ferrini, C. Salio, L. Lossi, M. Baratta, and A. Merighi The Gastrointestinal Hormone Ghrelin Modulates Inhibitory Neurotransmission in Deep Laminae of Mouse Spinal Cord Dorsal Horn Endocrinology, May 1, 2008; 149(5): 2306 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yukawa, D. S. Weigle, C. D. Davis, B. T. Marck, and T. Wolden-Hanson Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1453 - R1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Mager, M. Kolehmainen, V. D F de Mello, U. Schwab, D. E Laaksonen, R. Rauramaa, H. Gylling, M. Atalay, L. Pulkkinen, and M. Uusitupa Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome. Eur. J. Endocrinol., April 1, 2008; 158(4): 499 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Garcia, J. P. Cata, P. M. Dougherty, and R. G. Smith Ghrelin Prevents Cisplatin-Induced Mechanical Hyperalgesia and Cachexia Endocrinology, February 1, 2008; 149(2): 455 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Moran, M. Noakes, P. M Clifton, G. A Wittert, C. W Le Roux, M. A Ghatei, S. R Bloom, and R. J Norman Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1603 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Thomas, J. I. Andrews, and K. Z. Liu Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta FASEB J, December 1, 2007; 21(14): 3885 - 3895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wu, M. Zhou, P. Das, W. Dong, Y. Ji, D. Yang, M. Miksa, F. Zhang, T. S. Ravikumar, and P. Wang Ghrelin inhibits sympathetic nervous activity in sepsis Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1697 - E1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wu, W. Dong, M. Zhou, F. Zhang, C. P. Marini, T. S. Ravikumar, and P. Wang Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in Rats Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 805 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H St-Pierre, J.-P. Bastard, L. Coderre, M. Brochu, A. D Karelis, M.-E. Lavoie, F. Malita, J. Fontaine, D. Mignault, K. Cianflone, et al. Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: a MONET study Eur. J. Endocrinol., October 1, 2007; 157(4): 419 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vila, C. Maier, M. Riedl, P. Nowotny, B. Ludvik, A. Luger, and M. Clodi Bacterial Endotoxin Induces Biphasic Changes in Plasma Ghrelin in Healthy Humans J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3930 - 3934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Flynn, B. K. McFarlin, and M. M. Markofski State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 220 - 235. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Baessler, M. Fischer, B. Mayer, M. Koehler, S. Wiedmann, K. Stark, A. Doering, J. Erdmann, G. Riegger, H. Schunkert, et al. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease Hum. Mol. Genet., April 15, 2007; 16(8): 887 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Avallone, A. Demers, A. Rodrigue-Way, K. Bujold, D. Harb, S. Anghel, W. Wahli, S. Marleau, H. Ong, and A. Tremblay A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway Mol. Endocrinol., December 1, 2006; 20(12): 3165 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Dixit, A. T. Weeraratna, H. Yang, D. Bertak, A. Cooper-Jenkins, G. J. Riggins, C. G. Eberhart, and D. D. Taub Ghrelin and the Growth Hormone Secretagogue Receptor Constitute a Novel Autocrine Pathway in Astrocytoma Motility J. Biol. Chem., June 16, 2006; 281(24): 16681 - 16690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Tritos and E. G. Kokkotou The Physiology and Potential Clinical Applications of Ghrelin, a Novel Peptide Hormone Mayo Clin. Proc., May 1, 2006; 81(5): 653 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Granado, T. Priego, A. I. Martin, M{a} A. Villanua, and A. Lopez-Calderon Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1007 - E1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tesauro, F. Schinzari, M. Iantorno, S. Rizza, D. Melina, D. Lauro, and C. Cardillo Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome Circulation, November 8, 2005; 112(19): 2986 - 2992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wu, W. Dong, M. Zhou, X. Cui, H. Hank Simms, and P. Wang Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1 Cardiovasc Res, November 1, 2005; 68(2): 318 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Suematsu, A. Katsuki, Y. Sumida, E. C Gabazza, S. Murashima, K. Matsumoto, N. Kitagawa, H. Akatsuka, Y. Hori, K. Nakatani, et al. Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects Eur. J. Endocrinol., September 1, 2005; 153(3): 403 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gavrila, W. G. Li, M. L. McCormick, M. Thomas, A. Daugherty, L. A. Cassis, F. J. Miller Jr, L. W. Oberley, K. C. Dellsperger, and N. L. Weintraub Vitamin E Inhibits Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1671 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wynne, K. Giannitsopoulou, C. J. Small, M. Patterson, G. Frost, M. A. Ghatei, E. A. Brown, S. R. Bloom, and P. Choi Subcutaneous Ghrelin Enhances Acute Food Intake in Malnourished Patients Who Receive Maintenance Peritoneal Dialysis: A Randomized, Placebo-Controlled Trial J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2111 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Smith, L. Betancourt, and Y. Sun Molecular Endocrinology and Physiology of the Aging Central Nervous System Endocr. Rev., April 1, 2005; 26(2): 203 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. De Vriese, F. Gregoire, P. De Neef, P. Robberecht, and C. Delporte Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation Endocrinology, March 1, 2005; 146(3): 1514 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Leslie Opposites Detract Sci. Aging Knowl. Environ., July 14, 2004; 2004(28): nf65 - nf65. [Abstract] [Full Text]
|
|